Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 27, 2008 Brian Orelli	Super Seed Swap Instead of continuing to fight each other in court, agribusiness companies Syngenta and Monsanto called a truce for their never-ending patent disputes last week.
The Motley Fool May 6, 2009 Brian Orelli	Monsanto Kills the Love Monsanto announces that it's suing DuPont over a claimed misuse of Monsanto's herbicide-tolerant Roundup Ready technology.
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
The Motley Fool December 7, 2009 Jordan DiPietro	How Terrible Is Monsanto? Monsanto, the global provider of agricultural products, finds its reputation being slammed in a recent food documentary, Food Inc. Which is Monsanto -- savior or sinner?
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool August 29, 2008 Brian Orelli	Monsanto Seeds Its Pipeline A continued partnership with Evogene should result in higher yields.
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
BusinessWeek March 13, 2006 Gene G. Marcial	How Syngenta's Garden Grows Although it is a big global player in seeds and crop protection, Switzerland's $16 billion market cap Syngenta it gets scant attention on the Street.
The Motley Fool July 15, 2010 Brian Orelli	Insider Buying at Monsanto Monsanto's CEO and CFO bought shares. Should you?
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool October 15, 2010 Tim Hanson	Monsanto's Pain Is Syngenta's Gain Monsanto may be down, but Syngenta and others in the sector are on the upswing.
The Motley Fool January 8, 2009 Brian Orelli	Monsanto's Back! Monsanto blew the doors off Wall Street's estimates, and raised yearly guidance by 5% at the low end.
The Motley Fool June 29, 2010 Brian Orelli	Foolish Forecast: Monsanto 2.0 With Monsanto's herbicide Roundup facing cheap generic competition, the agriculture giant has planted its hopes for growth solely in the field of biotech seeds.
The Motley Fool January 11, 2008 David Lee Smith	DuPont's Growing Down on the Farm DuPont, the big Delaware-based chemicals company, sees its agricultural businesses flourish to such an extent that management has strengthened the company's earnings expectations for both 2007 and 2008.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool July 21, 2009 Brian Orelli	Monsanto and Dow Create Super Corn Sometimes you need a little help from a friend.
The Motley Fool May 20, 2011 Anupama Pattanaik	Danisco and DuPont: A Delicious Duet? What chemicals and food ingredients have in common.
The Motley Fool September 29, 2010 Brian Orelli	Monsanto's SmartStax Isn't Stacking Up It's hard to live up to the hype of SmartStax corn, which combines eight different traits to protect against bugs and make them resistant to herbicides used to kill weeds.
The Motley Fool April 2, 2009 Brian Orelli	Monsanto Rounds Up Alternative Growth Forget Roundup. The agri-giant has a better plan.
BusinessWeek April 29, 2010 Kaskey & Ligi	The Seed Makers Who Don't Pray for Rain Agricultural companies tweak crops to flourish with less.
The Motley Fool June 30, 2008 Brian Orelli	Will the Agriculture Sector Bust? Prices can't go up forever.
The Motley Fool October 7, 2005 Stephen D. Simpson	Nothing Seedy About UAP Although agriculture is not really a growth industry, this well-run supplier is generating solid returns on capital. UAP Holdings' stock is at least worth watching.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
The Motley Fool July 17, 2007 Brian Orelli	A Fruitful Collaboration Monsanto and BASF team up to grow better plants. Long-term investors should take it as a sign that Monsanto and BASF are putting their capital to good use.
The Motley Fool July 29, 2010 David Lee Smith	Under New Management, DuPont Cruises Ellen Kullman, who has been DuPont's CEO since 2008, has breathed life into a previously lackluster company.
The Motley Fool April 3, 2008 Brian Orelli	Monsanto's Planting Its Seeds Strong growth from the agricultural giant, but will it last?
The Motley Fool January 28, 2004 W.D. Crotty	Playing DuPont Ping-Pong What's an investor to make of DuPont's ping-pong strategy?
The Motley Fool April 15, 2009 Brian Orelli	No Bumper Crop, but Bans Aplenty for Monsanto Germany's move to ban planting of Monsanto's genetically modified corn seeds won't be a major hit to sales, but it's the thought that counts.
The Motley Fool January 15, 2010 Brian Orelli	Monsanto Rounds Up Documents for the DOJ The government investigates the agriculture giant.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool September 12, 2008 Brian Orelli	Monsanto Makes Half a Discovery Monsanto announces that it has sequenced the DNA of one of its "top-performing elite" lines of corn.
Chemistry World April 12, 2013 Anbdrew Turley	DuPont and Monsanto settle Roundup dispute Two US chemical heavyweights -- DuPont and agrichemical company Monsanto -- have agreed to drop a long running intellectual property dispute to make way for a series of licensing deals worth at least $1.75 billion.
The Motley Fool February 27, 2009 Brian Orelli	Hooray for Stalemates! Government deadlock will likely bring more genetically engineered seeds to the EU, and good news for Syngenta, DuPont, and Dow Chemical.
The Motley Fool August 8, 2005 Stephen D. Simpson	A Vanguard Among Small Caps? The chemicals company American Vanguard has an intriguing business model, but the valuation is too steep.
The Motley Fool October 27, 2010 David Lee Smith	DuPont's Decline Was Patently Explainable While DuPont saw declining earnings, its future continues to brighten.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool March 26, 2008 Brian Orelli	Monsanto's Guidance Grows Like a Weed The company has had good reasons to set its sights higher. Can Monsanto's current upbeat news keep going strong?
The Motley Fool September 17, 2010 Dave Mock	3 Reasons to Sell Monsanto Today Monsanto faces serious competitive threats on several fronts, threats that could continue to pressure the stock.